Legalizing Cannabis Experiences, Lessons and Scenarios
Produktdetaljer
Biographical note
Tom Decorte is Professor of Criminology and Director of the Institute for Social Drug Research (ISD) at Ghent University (Belgium). He is co-founder of the Global Cannabis Cultivation Research Consortium (GCCRC). His research interests include patterns of substance use, on the supply side of cannabis markets, and on the implementation of local drug monitoring systems. He has been advisor to a range of organizations on policies to improve public health relating to the use of drugs around the world.
Simon Lenton is a Professor and Director of the National Drug Research Institute at Curtin University, Australia, and works part time as a clinical psychologist. He has published widely on drugs, health and the law and provided advice to a range of government and private organizations on evidence-based drug policy and other drug issues.
Chris Wilkins is Associate Professor and is the leader of the drug research team at SHORE & WhÄriki Research Centre, Massey University, New Zealand. He has researched drug trends, drug markets and drug policy change. Dr Wilkins has been an invited speaker at international meetings in Europe, the United States and Australia.
<p><em>"As more countries look to follow evidence-based policies on drug law reform, this book is a welcome addition to the literature on this subject. The "war on drugs" has been a failure. Policy-makers need to know what the alternatives to futile attempts to prohibit drugs are. This book draws on the work of international experts to explore such options."</em> -<strong>Rt Hon Helen Clark</strong>, Former Prime Minister of New Zealand and Member of the Global Commission on Drug Policy.</p><p>"This is a comprehensive account of the diverse forms that cannabis legalization has taken in recent years, with a separate chapter telling the story and considering the lessons for each case, ranging from Uruguay to Spain to Canada, with US states, Jamaica, the Netherlands and other places in between. Other chapters consider lessons for cannabis control from regulation of alcohol and of tobacco, and from New Zealandâs attempts to regulate "legal highs". Itâs a "must read" for anyone interested in drug policy: its histories are memorable, its interpretations thought-provoking. Itâs worthwhile reading too for anyone interested in market regulation, in public health policy, or in law reform." - <strong>Prof. Robin Room</strong>, Centre for Alcohol Policy Research, La Trobe University.</p><p>"Professors Decorte, Lenton, and Wilkins have assembled a global all-star team of drug policy researchers for this excellent book. Itâs a must read for those seeking new insights about the past, present, and future of cannabis legalization." <strong>- Dr. Beau Kilmer</strong>, coauthor of <i>Marijuana Legalization: What Everyone Needs to Know</i> and director of the RAND Drug Policy Research Center</p><p>CHOICE, October 2021 Vol. 59 No. 2:</p><p><em>"From 1964 through 1989 the Single Convention on Narcotic Drugs predicted that non-medical use of cannabis ingredients would be eliminated throughout the world. This prediction never materialized. Instead, the marijuana market in the US alone was estimated at $2.3 billion in 2019 and was expected to reach $4.5 billion in 2020. The UN reported that approximately 250 million people use marijuana globally, making it the most widely used illicit drug in the world. This volume is thus a must-read to understand the legalization trends in other nations, what the nature of future cannabis legalization will be, and how regulation of other drugs such as tobacco and alcohol can inform the necessary regulation of marijuana markets. This book should appeal to public health enthusiasts with an interest in learning about the experiences, lessons, and scenarios of countries around the world that struggle to create public policy to address the rapidly growing international marijuana markets, which have been flourishing recently with the rise in medicinal marijuana use and the growth of recreational marijuana use. This reviewer strongly recommends this volume for anyone interested in understanding the growth of international drug markets." - </em><strong>P. J. Venturelli</strong>, Emeritus, Valparaiso University</p><p>Summing Up: <strong>Highly recommended</strong>. Advanced undergraduates through faculty; professionals.</p>
Produktdetaljer
Biographical note
Tom Decorte is Professor of Criminology and Director of the Institute for Social Drug Research (ISD) at Ghent University (Belgium). He is co-founder of the Global Cannabis Cultivation Research Consortium (GCCRC). His research interests include patterns of substance use, on the supply side of cannabis markets, and on the implementation of local drug monitoring systems. He has been advisor to a range of organizations on policies to improve public health relating to the use of drugs around the world.
Simon Lenton is a Professor and Director of the National Drug Research Institute at Curtin University, Australia, and works part time as a clinical psychologist. He has published widely on drugs, health and the law and provided advice to a range of government and private organizations on evidence-based drug policy and other drug issues.
Chris Wilkins is Associate Professor and is the leader of the drug research team at SHORE & WhÄriki Research Centre, Massey University, New Zealand. He has researched drug trends, drug markets and drug policy change. Dr Wilkins has been an invited speaker at international meetings in Europe, the United States and Australia.